VBI Vaccines, Inc. - Ordinary Shares (VBIV): Price and Financial Metrics

VBIV POWR Grades

• VBIV scores best on the Growth dimension, with a Growth rank ahead of 46.21% of US stocks.
• The strongest trend for VBIV is in Growth, which has been heading up over the past 147 days.
• VBIV's current lowest rank is in the Quality metric (where it is better than 2.23% of US stocks).

VBIV Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for VBIV is 0.02 -- better than only 9.75% of US stocks.
• With a price/sales ratio of 68.26, VBI VACCINES INC has a higher such ratio than 97.09% of stocks in our set.
• As for revenue growth, note that VBIV's revenue has grown 71.47% over the past 12 months; that beats the revenue growth of 89.48% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to VBI VACCINES INC are NVVE, WEAV, DMTK, ASPN, and WRAP.
• Visit VBIV's SEC page to see the company's official filings. To visit the company's web site, go to www.vbivaccines.com.

VBIV Valuation Summary

• In comparison to the median Healthcare stock, VBIV's price/sales ratio is 3494.74% higher, now standing at 68.3.
• VBIV's price/sales ratio has moved NA NA over the prior 219 months.

Below are key valuation metrics over time for VBIV.

VBIV Growth Metrics

Its 5 year net income to common stockholders growth rate is now at -109.29%.
• The year over year net cashflow from operations growth rate now stands at -15.51%.
• Its 3 year net cashflow from operations growth rate is now at -4.34%.

VBIV's revenue has moved down $1,351,000 over the prior 33 months.

The table below shows VBIV's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	0.87	-73.165	-110.945
2022-06-30	0.66	-59.921	-101.583
2022-03-31	0.456	-53.189	-73.36
2021-12-31	0.631	-39.908	-69.753
2021-09-30	0.714	-37.887	-66.332
2021-06-30	0.905	-48.957	-63.482

VBIV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VBIV has a Quality Grade of F, ranking ahead of 2.02% of graded US stocks.
• VBIV's asset turnover comes in at 0.004 -- ranking 418th of 681 Pharmaceutical Products stocks.
• NOVN, CKPT, and ARWR are the stocks whose asset turnover ratios are most correlated with VBIV.

The table below shows VBIV's key quality metrics over time.